What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Clin Immunol. 2017 Sep:182:14-23. doi: 10.1016/j.clim.2017.05.001. Epub 2017 May 3.

Abstract

For decades, Sjögren's syndrome (SS) and Sjögren's syndrome-like (SS-like) disease in patients and mouse models, respectively, have been intensely investigated in attempts to identify the underlying etiologies, the pathophysiological changes defining disease phenotypes, the nature of the autoimmune responses, and the propensity for developing B cell lymphomas. An emerging question is whether the generation of a multitude of mouse models and the data obtained from their studies is actually important to the understanding of the human disease and potential interventional therapies. In this brief report, we comment on how and why mouse models can stimulate interest in specific lines of research that apparently parallel aspects of human SS. Focusing on two mouse models, NOD and B6·Il14α, we present the possible relevance of mouse models to human SS, highlighting a few selected disease-associated biological processes that have baffled both SS and SS-like investigations for decades.

Keywords: B cell lymphomagenesis; Interferon signature; Mouse models; Signal transduction pathways; Sjögren's syndrome.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autoimmunity / genetics
  • Autoimmunity / immunology
  • Disease Models, Animal*
  • Humans
  • Interferons / genetics
  • Interferons / immunology
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / immunology
  • Mice*
  • Mice, Transgenic
  • RNA Viruses / genetics
  • RNA Viruses / immunology
  • RNA, Double-Stranded
  • Sjogren's Syndrome / genetics
  • Sjogren's Syndrome / immunology*
  • Transcriptome

Substances

  • RNA, Double-Stranded
  • Interferons